Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Equity (Deficit)

v3.22.2.2
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Previously Reported
Convertible Preferred Stock
Convertible Preferred Stock
Previously Reported
Convertible Preferred Stock
Revision of Prior Period, Adjustment
Contingently Redeemable Convertible Common Stock
Contingently Redeemable Convertible Common Stock
Previously Reported
 [3]
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Accumulated
Deficit
Accumulated
Deficit
Previously Reported
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2020 [1]     114,795,000 97,611,000 17,184,000                  
Temporary equity, balances at beginning of period at Dec. 31, 2020 [1]     $ 487,918 $ 487,918                    
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2021 [1],[2]     114,795,000                      
Temporary equity, balances at ending of period at Sep. 30, 2021 [1],[2]     $ 487,918                      
Balances at beginning of period (in shares) at Dec. 31, 2020 [1]               8,468,000 7,200,000 1,268,000        
Balances at beginning of period at Dec. 31, 2020 $ (339,641) $ (339,641)           $ 1 [1] $ 1 [1]   $ 14,605 $ 14,605 $ (354,247) $ (354,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Conversion of preferred stock warrant liability to common stock warrants 1,622                   1,622      
Issuance of common stock upon exercise of warrants (in shares)               286,000            
Issuance of common stock upon exercise of warrants 150                   150      
Issuance of common stock for services (in shares) [1]               4,000            
Issuance of common stock for services 49                   49      
Issuance of common stock upon exercise of stock options (in shares) [1]               581,000            
Issuance of common stock upon exercise of stock options 591                   591      
Vesting of early exercise of options 1,413                   1,413      
Repurchase of early exercised options (in shares) [1]               (155,000)            
Stock-based compensation 11,007                   11,007      
Net income (loss) (103,909)                       (103,909)  
Balances at ending of period (in shares) at Sep. 30, 2021 [1],[2]               9,184,000            
Balances at ending of period at Sep. 30, 2021 (428,718)             $ 1 [1],[2]     29,437   (458,156)  
Temporary equity, balances at beginning of period (in shares) at Jun. 30, 2021 [2]     114,795,000 97,611,000 17,184,000                  
Temporary equity, balances at beginning of period at Jun. 30, 2021 [2]     $ 487,918 $ 487,918                    
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2021 [1],[2]     114,795,000                      
Temporary equity, balances at ending of period at Sep. 30, 2021 [1],[2]     $ 487,918                      
Balances at beginning of period (in shares) at Jun. 30, 2021 [2]               8,839,000 7,516,000 1,323,000        
Balances at beginning of period at Jun. 30, 2021 (395,275) (395,275)           $ 1 [2] $ 1 [2]   25,382 25,382 (420,658) (420,658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of common stock upon exercise of warrants (in shares)               286,000            
Issuance of common stock upon exercise of warrants 150                   150      
Issuance of common stock upon exercise of stock options (in shares) [2]               59,000            
Issuance of common stock upon exercise of stock options 74                   74      
Vesting of early exercise of options 168                   168      
Stock-based compensation 3,663                   3,663      
Net income (loss) (37,498)                       (37,498)  
Balances at ending of period (in shares) at Sep. 30, 2021 [1],[2]               9,184,000            
Balances at ending of period at Sep. 30, 2021 $ (428,718)             $ 1 [1],[2]     29,437   (458,156)  
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 114,795,034   114,795,000 [3] 97,611,000 [3] 17,184,000 [3] 0 [3] 0              
Temporary equity, balances at beginning of period at Dec. 31, 2021 $ 487,918   $ 487,918 [3] $ 487,918 [3]   $ 0 [3] $ 0              
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Issuance of preferred stock and common stock upon net exercise of warrants ( in shares) [3]     168,000                      
Issuance of preferred stock and common stock upon exercise of warrants [3]     $ 989                      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [3]     (114,963,000)     (2,750,000)                
Convertible preferred stock and contingently redeemable common stock conversion [3]     $ (488,907)     $ (27,473)                
Issuance of convertible common stock (in shares) [3]           2,750,000                
Issuance of convertible common stock [3]           $ 27,473                
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2022 0   0 [3],[4]     0 [3],[4]                
Temporary equity, balances at ending of period at Sep. 30, 2022 $ 0   $ 0 [3],[4]     $ 0 [3],[4]                
Balances at beginning of period (in shares) at Dec. 31, 2021 [3]               9,368,000 7,966,000 1,402,000        
Balances at beginning of period at Dec. 31, 2021 (456,279) $ (456,279)           $ 1 [3] $ 1 [3]   33,863 $ 33,863 (490,143) $ (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of shares under ELOC Agreement (in shares)               41,000            
Issuance of shares under ELOC Agreement 138                   138      
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [3]               180,000            
Issuance of preferred stock and common stock upon exercise of warrants 12                   12      
Conversion of preferred stock warrant liability to common stock warrants 2,182                   2,182      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [3]               118,205,000            
Convertible preferred stock and contingently redeemable common stock conversion 516,380             $ 12 [3]     516,368      
Issuance of common stock in connection with Business Combination, net of $17.8 million in transaction costs (in shares) [3]               20,921,000            
Issuance of common stock in connection with Business Combination, net of $17.6 million in transaction costs 79,468             $ 2 [3]     79,466      
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)                   (93,196)      
Issuance of Earn-Out Shares (in shares) [3]               14,000,000            
Issuance of Earn-Out Shares 1             $ 1 [3]            
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [3]               32,000            
Issuance of Class A common stock issued to employees, net of withholding taxes (96)                   (96)      
Issuance of shares to settle additional shares liability (in shares)               3,275,000            
Issuance of shares to settle Additional Shares Liability $ 16,310                   16,310      
Issuance of common stock upon exercise of stock options (in shares) 216,856             216,000 [3]            
Issuance of common stock upon exercise of stock options $ 354                   354      
Vesting of early exercise of options 125                   125      
Repurchase of early exercised options (in shares) [3]               (17,000)            
Stock-based compensation 34,668                   34,668      
Net income (loss) (75,032)                       (75,032)  
Balances at ending of period (in shares) at Sep. 30, 2022 [3],[4]               166,221,000            
Balances at ending of period at Sep. 30, 2022 $ 25,035             $ 16 [3],[4]     590,194   (565,175)  
Temporary equity, balances at beginning of period (in shares) at Jun. 30, 2022 [4]     0     0                
Temporary equity, balances at beginning of period at Jun. 30, 2022 [4]     $ 0     $ 0                
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Issuance of shares under ELOC Agreement (in shares) [4]     0                      
Issuance of shares under ELOC Agreement [4]     $ 0                      
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2022 0   0 [3],[4]     0 [3],[4]                
Temporary equity, balances at ending of period at Sep. 30, 2022 $ 0   $ 0 [3],[4]     $ 0 [3],[4]                
Balances at beginning of period (in shares) at Jun. 30, 2022 [4]               162,870,000            
Balances at beginning of period at Jun. 30, 2022 (8,478)             $ 16 [4]     564,343   (572,837)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Issuance of shares under ELOC Agreement (in shares) [4]               41,000            
Issuance of shares under ELOC Agreement 138                   138      
Issuance of common stock in connection with Business Combination, net of $17.6 million in transaction costs (513)                   (513)      
Issuance of shares to settle additional shares liability (in shares)               3,275,000            
Issuance of shares to settle Additional Shares Liability 16,310                   16,310      
Issuance of common stock upon exercise of warrants (in shares)               24,000            
Issuance of common stock upon exercise of warrants 12                   12      
Issuance of common stock upon exercise of stock options (in shares) [4]               11,000            
Issuance of common stock upon exercise of stock options 21                   21      
Stock-based compensation 9,883                   9,883      
Net income (loss) 7,662                       7,662  
Balances at ending of period (in shares) at Sep. 30, 2022 [3],[4]               166,221,000            
Balances at ending of period at Sep. 30, 2022 $ 25,035             $ 16 [3],[4]     $ 590,194   $ (565,175)  
[1] (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
[2]
(1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
[3]
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
[4] The accompanying notes are an integral part of these condensed consolidated financial statements.